NFKB1 and Insulin resistance: TLR4 signaling leads to the activation of the NFκB pathway [48,49], which results in the secretion of inflammatory mediators (e.g., TNFα, MCP-1, and IL-6) and stimulates insulin resistance [32,50,51].